![](/img/cover-not-exists.png)
The BCR-ABL inhibitor ponatinib inhibits platelet immunoreceptor tyrosine-based activation motif (ITAM) signaling, platelet activation and aggregate formation under shear
Loren, Cassandra P., Aslan, Joseph E., Rigg, Rachel A., Nowak, Marie S., Healy, Laura D., Gruber, András, Druker, Brian J., McCarty, Owen J.T.Volume:
135
Language:
english
Journal:
Thrombosis Research
DOI:
10.1016/j.thromres.2014.11.009
Date:
January, 2015
File:
PDF, 757 KB
english, 2015